400例参麦注射液合理用药情况分析
Analysis of the rational use of Shenmai injection of 400 cases
毕铁琳 1于倩 1郭义明1
作者信息
- 1. 吉林大学中日联谊医院 药学部,吉林 长春 130033
- 折叠
摘要
目的 分析评价参麦注射液的临床实际用药情况,促进参麦注射液的合理使用.方法 采用回顾性分析的方法,从吉林大学中日联谊医院医院系统(hospital information system,HIS)中随机抽取2015年全年使用参麦注射液的400份病历进行点评,用EXCEL汇总数据并进行评价.结果 400例病历中,使用参麦注射液的临床科室共有11个,其中心血管内科为347例(86.75%),超适应症用药84例(21.00%),溶媒使用不规范287例(71.75%),存在说明书中配伍禁忌的占105例(26.25%).未发现与参麦注射液相关的不良反应.结论 参麦注射液的临床使用有诸多不规范之处,应严格按照药品说明书合理使用参麦注射液,规避超说明书用药带来的风险.
Abstract
Objective To analyse the clinical usage of Shenmai injection, promote the rational use of Shenmai injection. Methods 400 hospital medical records that used Shenmai injection in 2015 were collected and reviewed from hospital information system (HIS) by retrospective analysis method, aggregated and evaluated data by EXCEL. Results In 400 cases, 11 clinical departments used the Shenmai injection, mainly in cardiology of 347 cases(86.75%).The percentage of the non-standard clinical application of Shenmai injection was 84 cases (21.00%). The non-standardized rates of solvent dispensing was 287 cases (71.75%), and the specification incompatibility accounted for 105 cases (26.25%). There was no adverse drug reaction of Shenmai injection. Conclusion The clinical use of Shenmai injection is not yet standardized, which suggests that drugs should be strictly used in accordance with the instruction, in order to avoid risks of off-label use.
关键词
参麦注射液/合理用药/病历点评Key words
Shenmai injection/rational use of drug/case review引用本文复制引用
出版年
2017
NETL
NSTL
维普
万方数据